Joseph K. Belanoff - 24 Dec 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: CORT
Reported as of: 24 Dec 2025
Net transaction value: -$23,515,257
SEC form: 4
Accepted by SEC: 29 Dec 2025, 17:24:48 UTC
Prior SEC filing: 03 Dec 2025
Next SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff.

Key filing fact

Joseph K. Belanoff filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 29 Dec 2025.

Key facts

This page summarizes Joseph K. Belanoff's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 Dec 2025, 17:24.

Change

Previous filing in this sequence was filed on 03 Dec 2025.
Current net transaction value: -$23,515,257.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001286199 Primary reporting owner

BELANOFF JOSEPH K

Relationship: Chief Executive Officer, Director
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff.
Signature date: 29 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Options Exercise

Transaction value: $2,134,000
Shares: +550,000
Change %
Price: $3.88
Shares after: 550,000
Date: 24 Dec 2025
Ownership: Direct

CORT transaction

Common Stock

Tax liability

Transaction value: $25,649,257
Shares: -306,846
Change %: -56%
Price: $83.59
Shares after: 243,154
Date: 24 Dec 2025
Ownership: Direct
Footnotes: F1

CORT transaction

Common Stock

Gift

Transaction value: $0
Shares: -243,154
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 24 Dec 2025
Ownership: Direct

CORT transaction

Common Stock

Other

Transaction value: $0
Shares: +243,154
Change %: +9%
Price: $0.000000
Shares after: 2,944,524
Date: 24 Dec 2025
Ownership: Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value: $0
Shares: -550,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 24 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 550,000
Exercise price: $3.88
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options.

Footnote F2

Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02.

Footnote F3

Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Footnote F4

Fully exercisable.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.